Added to YB: 2025-06-20
Pitch date: 2025-06-17
HIMS [neutral]
Hims & Hers Health, Inc.
-73.84%
current return
Author Info
Company Info
Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally.
Market Cap
$3.7B
Pitch Price
$60.48
Price Target
N/A
Dividend
N/A
EV/EBITDA
23.63
P/E
30.31
EV/Sales
1.90
Sector
Health Care Providers and Services
Category
N/A
HIMS: Another (Misleading) GLP-1 PR Claim
HIMS (update - short): Personalized GLP-1 program shows 60% retention at 3 months, worse than commercial Wegovy's 70% in JPM/Gleason data. CEO Dudum misleadingly claims superior outcomes vs BCBS study. Concerning: 90k personalized users signals potential mass prescribing, which may violate compounding laws. Regulatory/Novo inaction puzzling.
Read full article (9 min)